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Synthesis and antibacterial activities of aspirin-chalcone derivatives 
 
PHANG SAI FOONG 
 
Department of Chemistry 
Faculty of Resource Science and Technology 
University Malaysia Sarawak 
Abstract 
In recent years, chalcone and its derivatives have been studied extensively in terms of their 
biological activities. In this study, the synthesis and characterization of aspirin-chalcone 
derivatives has been carried out. A series of aspirin-chalcone derivatives were successfully 
synthesized from the reaction of intermediates 31a-c with acetylsalicyloyl chloride to yield 
final product of 32a-c with overall yield of 21.8 % to 88.4 %. All the derivatives were 
characterized by FT-IR, 1HNMR and 13CNMR. Disc diffusion method was then used to 
study the antibacterial activities of the new series. All of them showed the results of poor 
antibacterial properties. The structure that affected the strength of antibacterial properties 
was discussed. 




Dalam tahun-tahun kebelakangan ini, chalcone dan derivatifnya telah dikaji secara meluas 
dari segi aktiviti biologi mereka. Dalam kajian ini, sintesis dan pencirian derivatif aspirin - 
chalcone telah dijalankan. Satu siri derivatif aspirin - chalcone telah berjaya disintesis 
daripada reaksi 31a-c dengan klorida acetylsalicyloyl untuk menghasilkan 32a-c dengan 
hasil keseluruhan 21.8 % - 88.4 %. Semua derivatif telah dicirikan oleh FT- IR, 1HNMR dan 
13CNMR . Kaedah cakera resapan telah digunakan untuk mengkaji aktiviti antibakteria siri 
baru. Semua produk menunjukkan keputusan ciri-ciri antibakteria yang lemah. Struktur 
yang menjejaskan kekuatan ciri-ciri antibakteria telah dibincangkan . 
 








Aspirin 1 is known as acetylsalicylic acid. It is a salicylate drug, which is used as an analgesic 
to relieve pains and minor aches. In addition, aspirin is antipyretic and always being applied 
to reduce fever and prescribed as an anti-inflammatory medication. For now, aspirin 
modifications have been conducted widely and many aspirin derivatives were proven to 
exhibit various biological properties such as antithrombic and antiplatelet (Lechi et al., 1996), 
anticancer (Lechi et al., 1996; Zheng et al., 2007) and antibacterial properties (Al-Bakri et 
al., 2009). According to Karthikeyan et al. (2009), in the meta-analysis performed by the 
Antiplatelet Trialists' Collaboration, aspirin is reported to reduce the incidence of deep-vein 
thrombosis by 20% and that of pulmonary embolism by 69% in patients that have high risk 
for thromboembolic events. 
 
1 
Figure 1.1 : Structure of aspirin 
 
1.2 Chalcone 
Chalcone 2 is known as a group of compound consisting of two aromatic rings linked by an 
unsaturated α and β-ketone. There are various types of substituents on those two aromatic 
rings. Chalcone exists in most of the plants in nature. It is an intermediate precursor of 
  
flavonoids and isoflavonoids. Chalcone has been applied widely in the field of biology and 
chemistry. Chalcone showed many biological properties including anticancer, antimalarial, 
antimicrobial, anti-inflammatory and antibacterial (Hsieh et al., 1998; Ram et al., 2000). In 
chemistry field, some studies showed that the photochemical and photophysical properties 
of chalcone enables it to be used as photoalignment and photocrosslinking unit in 
polymerization process, fluorescent dyes and light-emitting diodes (LEDs). 
 
2 
Figure 1.2 : Structure of chalcone 
1.3 Problem Statement 
Currently, there are less studies conducted on synthesizing aspirin-chalcone derivatives. So, 
we would like to conduct this study by synthesizing aspirin-chalcone derivatives with 
various substituents. Through the structure modification, it is possible to create a product 
which contains even stronger antibacterial properties. 
1.4 Objectives 
1. To synthesize hydroxyl chalcone derivatives with long alkyl chain. 
2. To incorporate hydroxyl chalcone derivatives onto aspirin. 
3. To characterize the synthesized compounds using FTIR, 1H and 13C NMR. 




2.0 Literature Review 
2.1 Aspirin 
Aspirin is synthesized by reacting acetic anhydride and salicylic acid through esterification 
reaction. Phosphoric acid is applied as catalyst to speed up the reaction. At the end of the 







 Scheme 1 : Synthesis of aspirin 
 
2.1.1 Recent study of aspirin derivatives 
In the study carried out by Li et al. (2014), a novel aspirin derivatives, namely Ca-ASP 3 
was prepared and characterized by reacting aspirin solution with hydroxylapatite (Hap) 
suspension. The anti-thrombotic and gastric mucosal protection properties study was carried 
out by using Winstar rats. Study shown that rats that consumed 5 mmol per kg body weight 
of Ca-ASP showed similar anti-thrombotic activity compared to those consumed same 
amount of aspirin, however, they suffered gastric mucosal damage in a much lower level 






Figure 2.1 : Structure of Ca-ASP 
 
In the study carried out by Balamani and Sekar (2011), simple new aspirin Enkephalin 
analogues were synthesized and evaluated for its analgesic activity studies. ACOH-inducing 
writhing test was then carried out on mice to evaluate their analgesic effects. The mean 
writhing values shown that Gly-Gly-Phe-Met-NH2 sequence was important for the observed 
analgesic activity of compound Aspirin-Gly-Gly-Phe-Met-NH2, while the Gly-Gly-Phe-




The general procedure to synthesis chalcone is by reacting equal molar of benzaldehyde and 
acetophenone in 95 % ethanol as a solvent. The mixture is stirred and cooled in an ice bath. 
To complete crystal the formation, it was filtered, wash in cold water and recrystallized with 





Scheme 2 : Synthesis of chalcone 
  
 
2.2.1 Antioxidant activity of chalcone derivatives 
The antioxidant activity of 2’-Omethylisoliquiritigenin 4, isolated from the roots of 
Dalbergia odorifera, in lard was examined by Yu et al. (2007) by using oxidative stability 
instrument. As a result, greater antioxidant effects was obtained from this chalcone at 0.1 
and 0.2 mM compared to butylated hydroxytoluene (BHT) and α-tocopherol. It was similar 
to α-tocopherol in inhibiting the decreasing of glutathione (GSH) level of rat lens induced 
by UV irradiation. The result could be useful to identify the mechanism of cataractogenesis.   
 
4 
Figure 2.2 : Structure of 2’-Omethylisoliquiritigenin 
 
From the study conducted by Mohamad et al. (2004), the 2’,3’,4’,6’-tetrahydroxychalcone 
5 isolated from dried ripe fruits of Alpinia rafflesiana exhibited more potent DPPH radical-
scavenging activity (IC50 = 55 μM) compared to vitamin C (IC50 = 91 μM) and α-tocopherol 
(IC50 = 96 μM). From the result, chalcones were found out to be potent radical scavengers if 
it has catechol pattern of substitution in ring B and pyrogallol-type hydroxylated ring A.  
 
5 
Figure 2.3 : Structure of 2’,3’,4’,6’-tetrahydroxychalcone 
 
 
2.2.2 Anti-inflammatory activity of chalcone derivatives 
  
Heme oxygenase 1 (HO-1) is known as crucial anti-inflammatory enzyme induced in 
response to oxidative stress and cytokines. A report by Sawle et al. (2008) stated that some 
methoxychalcones possessed anti-inflammatory activity that correlated with their potency 
as HO-1 inducers. By sequentially increasing the number of methoxy substituents in the 
3,4,5- and 3’,4’,5’-positions of the aryl rings, a progressive increase in HO-1 activity was 
obtained. Meanwhile, Jin et al. (2007) also reported that by the induction of HO-1, which 
was initiated by depletion of GSH, 2’,4’,6’-tris(methoxymethoxy)chalcone 6 exhibited 
potent anti-inflammatory activity.  
 
6 
Figure 2.4 : Structure of 2’,4’,6’-tris(methoxymethoxy)chalcone 
 
The flavokawin A 7 isolated from Piper methysticum by Folmer et al. (2006), inhibited 
tumor necrosis factor (TNF)-α-induced IκBα degradation and translocation of p50 and p65 
NF-κB subunits from the cytoplasm to the nucleus. Besides, important inflammation-related 
proteins such as p38-regulated/activated kinase, Iκβ kinase, Aurora B kinase, mitogen-
activated protein kinase 3, dual-specificity tyrosine-phosphorylated and regulated kinase 1A, 




Figure 2.5 : Structure of flavokawin A 
 
2.2.3 Anticancer activity of chalcone derivatives 
According to Amor et al. (2007), 2’,4’-dihydroxy-6’-methoxy-3’,5’-dimethylchalcone 8, 
isolated from Syzygium samarangense showed significant differential cytotoxicity against 
the adenocarcinoma SKBR-3 cell lines and human mammary MCF-7 with IC50 values of 
12.8 x 10-4 nM and 15 x 10-4 nM respectively. Compared to former, the positive control 
doxorubicin had an IC50 value of 27.6x10-4 nM against the SKBR-3 cells and an IC50 value 
of 2.6 x 10-4 nM against the MCF-7 cell line.  
 
8 
Figure 2.6 : Structure of 2’,4’-dihydroxy-6’-methoxy-3’,5’-dimethylchalcone 
Kimura et al. (2004) isolated 4-Hydroxyderricin 9 from Angelica keiskei. Given orally at a 
dose of 50 mg/kg x 2/day, this compound successfully inhibited lung metastasis and 
prolonged the survival time in mice after the removal of subcutaneous tumors by surgical 
operation. This compound had additional properties by inhibiting the reduction of the 
numbers of lymphocytes, CD4+, CD8+ and natural killer (NK)-T cells in the spleen of tumor-




Figure 2.7 : Structure of 4-Hydroxyderricin 
 
2.2.4 Anti-infective activity of chalcone derivatives 
2.2.4.1 Antibacterial activity 
Compound 10 identified by Bowman et al. (2007) was concluded the most active against S. 
aureus, methicillin-resistant S. aureus, S. epidermidis, and B. subtilis with the MIC values 
3.5, 3.0, 3.8, and 8.8 μM respectively. In comparison, the referent drug linezolid inhibited 
both S. aureus strains with recorded MIC values of 10.0 and 8.0 μM respectively.  
 
10 
Figure 2.8 : Structure of compound 10 
 
2.2.4.2 Antifungal activity                                                                                         
Mbaveng et al. (2008) screened isobavachalcone 11 for its antifungal activity, and found out 
that it inhibited growth of Microsporum audorium (MIC = 0.3 μg/ml), Candida albicans 





Figure 2.9 : Structure of isobavachalcone 
 
2.2.4.3 Antiviral activity 
An attempt was made by Deng et al. to develop small molecules to inhibit HIV-1 integrase 
(IN), a crucial enzyme for viral replication. Compound 12 was synthesized successfully and 
in the presence of both Mn2+ and Mg2+ as cofactors, it showed potent inhibitory activity with 
an IC50 value of 2 μM against purified IN. 
 
12 
Figure 2.10 : Structure of compound 12 
 
2.2.4.4 Antiparasitic activity 
Licochalcone A 13, the well-known antiparasitic compound is a potent membrane-active 
agent that undergoes transformation of normal erythrocytes into echinocytes in parallel with 
the inhibition of growth of P. falciparum cultures. Ziegler et al. (2004) managed to observed 





Figure 2.11 : Structure of licochalcone 
 
2.2.5 Recent studies of chalcone derivatives 
In the study conducted by Singh et al. (2010), a new pharmacophore named 
‘Chalconesemicarbazone’ was designed by pharmacophore hybridization of drug design. 
Singh et al. (2010) a series of novel ‘chalconylsemicarbazide’ derivatives by reacting 
substituted phenyl semicarbazide with various chalcone derivatives, which contained 
hydrogen acceptor site, hydrogen donor site and lipophilic site which may aid in receptors 
binding for pharmacological activities. Carrageenan-induced rat paw edema test was used to 
conduct in vivo determination of the anti-inflammatory activity. Meanwhile, to evaluate the 
analgesic activity, acetic acid-induced writhing test was used. Finally, the percentage of 
protection against the acetic acid-induced writhing was determined and calculated. The 
screening result shown that 1-(1,5-diphenylpenta-2,4-dienylidene)-4-(2-nitrophenyl) 
semicarbazide was most active.  
 
